Free Trial

Drugs Made In America Acquisition (DMAA) Institutional Ownership

Drugs Made In America Acquisition logo
$10.58 +0.01 (+0.09%)
Closing price 03:52 PM Eastern
Extended Trading
$10.57 -0.01 (-0.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Drugs Made In America Acquisition (NASDAQ:DMAA)

Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$32.95M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$12.32M
Get DMAA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Drugs Made In America Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DMAA Institutional Buying and Selling by Quarter

Drugs Made In America Acquisition Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2026Lineage Point Capital LP31,840$330K0.1%N/A0.109%
2/18/2026Toronto Dominion Bank200,000$2.08M0.0%-55.6%0.686%
2/18/2026Rivernorth Capital Management LLC417,998$4.34M0.2%+31.4%1.433%
2/18/2026Governors Lane LP250,000$2.59M0.2%+2,132.1%0.857%
2/18/2026Boothbay Fund Management LLC346,154$3.59M0.1%-30.8%1.187%
2/17/2026Polar Asset Management Partners Inc.1,600,000$16.60M0.2%-15.8%5.485%
2/17/2026Radcliffe Capital Management L.P.546,808$5.67M0.3%+3.5%1.875%
2/16/2026Clear Street Group Inc.325,973$3.38M0.0%+55.5%1.117%
2/13/2026DLD Asset Management LP100,559$1.04M0.1%-11.5%0.345%
2/13/2026Quarry LP266,551$2.77M0.5%+1,595.5%0.914%
2/13/2026Glazer Capital LLC1,816,428$18.84M0.5%-0.3%6.227%
2/13/2026L1 Global Manager Pty Ltd200,000$2.08M1.4%N/A0.686%
2/11/2026Mercuria Capital Strategies LLC750,000$7.51M6.2%N/A2.571%
2/2/2026 Wolverine Asset Management LLC1,307,468$13.56M0.1%+4.7%4.482%
1/1/2026JPMorgan Chase & Co.99,690$1.02M0.0%N/A0.342%
12/15/2025Hudson Bay Capital Management LP1,550,000$15.92M0.1%-13.9%5.314%
11/17/2025Quarry LP15,721$161K0.0%N/A0.054%
11/17/2025Clear Street Group Inc.209,566$2.15M0.0%N/A0.718%
11/17/2025Bulldog Investors LLP130,264$1.34M0.3%+78.5%0.447%
11/17/2025Boothbay Fund Management LLC500,000$5.14M0.1%-12.3%1.714%
11/14/2025Shaolin Capital Management LLC150,000$1.54M0.1%+50.0%0.514%
11/14/2025AQR Arbitrage LLC371,211$3.81M0.1%-1.4%1.273%
11/14/2025Sandia Investment Management LP15,721$161K0.5%N/A0.054%
11/14/2025Radcliffe Capital Management L.P.528,100$5.42M0.3%+316.7%1.810%
11/13/2025DLD Asset Management LP113,672$1.17M0.0%-39.8%0.390%
11/12/2025ATW Spac Management LLC500,000$5.14M6.7%-12.3%1.714%
11/12/2025Context Capital Management LLC250,000$2.57M0.1%N/A0.857%
11/7/2025JPMorgan Chase & Co.99,690$1.02M0.0%N/A0.342%
10/28/2025 Wolverine Asset Management LLC1,249,128$12.83M0.1%+22.2%4.282%
8/15/2025Radcliffe Capital Management L.P.126,722$1.29M0.1%N/A0.434%
8/15/2025Boothbay Fund Management LLC570,000$5.81M0.1%N/A1.954%
8/15/2025AQR Arbitrage LLC376,314$3.84M0.1%-1.1%1.290%
8/14/2025Shaolin Capital Management LLC100,000$1.02M0.0%N/A0.343%
8/14/2025Karpus Management Inc.2,744,109$27.99M0.9%+18.1%9.407%
8/13/2025Clear Street LLC112,615$1.15M0.0%N/A0.386%
8/13/2025DLD Asset Management LP188,722$1.93M0.0%-73.0%0.647%
8/4/2025 Wolverine Asset Management LLC1,021,906$10.42M0.1%+69.5%3.503%
8/1/2025Mizuho Securities USA LLC542,962$5.40M0.1%N/A1.861%


DMAA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DMAA shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Drugs Made In America Acquisition. The most heavily invested institutionals were Karpus Management Inc. ($27.99M), Glazer Capital LLC ($18.84M), Polar Asset Management Partners Inc. ($16.60M), Hudson Bay Capital Management LP ($15.92M), Wolverine Asset Management LLC ($13.56M), Mercuria Capital Strategies LLC ($7.51M), and Radcliffe Capital Management L.P. ($5.67M).Learn more on Drugs Made In America Acquisition's institutional investors.

Which institutional investors have been buying Drugs Made In America Acquisition's stock?

Of the 18 institutional investors that purchased Drugs Made In America Acquisition's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Mercuria Capital Strategies LLC ($750K), Wolverine Asset Management LLC ($704.43K), Boothbay Fund Management LLC ($570K), Radcliffe Capital Management L.P. ($546.81K), Mizuho Securities USA LLC ($542.96K), Karpus Management Inc. ($420.08K), and Clear Street Group Inc. ($325.97K).

How much institutional buying is happening at Drugs Made In America Acquisition?

Institutional investors have bought a total of 5,482,455 shares in the last 24 months. This purchase volume represents approximately $32.95M in transactions.

Which of Drugs Made In America Acquisition's major shareholders have been selling company stock?

The following institutional investors have sold Drugs Made In America Acquisition stock in the last 24 months: DLD Asset Management LP ($599.44K), Polar Asset Management Partners Inc. ($300K), Toronto Dominion Bank ($250K), Hudson Bay Capital Management LP ($250K), Boothbay Fund Management LLC ($223.85K), ATW Spac Management LLC ($70K), and AQR Arbitrage LLC ($9.10K).

How much institutional selling is happening at Drugs Made In America Acquisition?

Institutional investors have sold a total of 1,708,254 shares in the last 24 months. This volume of shares sold represents approximately $12.32M in transactions.



This page (NASDAQ:DMAA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners